Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children

European Journal of Immunology

Volumn 42, Issue 12, 2012, Pages 3256-3266

  Noyola, Daniel E ^a   Fortuny, Claudia ^b   Muntasell, Aura ^c   Noguera Julian, Antoni ^b   Muñoz Almagro, Carmen ^b   Alarcón, Ana ^b   Juncosa, Teresa ^b   Moraru, Manuela ^d   Vilches, Carlos ^d   López Botet, Miguel ^c,e  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^e UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Congenital infection; Cytomegalovirus; NK cells; NKG2C

Indexed keywords

CD94 ANTIGEN; CELL RECEPTOR;

ARTICLE; CELL COUNT; CHILD; CLINICAL ARTICLE; CONGENITAL INFECTION; COPY NUMBER VARIATION; CYTOMEGALOVIRUS INFECTION; FEMALE; GENE DELETION; GENOTYPE; HOMEOSTASIS; HOMOZYGOSITY; HUMAN; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PERINATAL PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL;

ANTIGENS, DIFFERENTIATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GENE DELETION; GENE DOSAGE; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; INFANT; INFANT, NEWBORN; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MALE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C;

EID: 84871267470     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242752     Document Type: Article

References (60)

1. Crumpacker, C. S., Cytomegalovirus. In Mandell, G. L., Bennett, J. E. and Dolin, R. (Eds.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, 2000, pp 1586-599.
2. Mocarski, E. S. and Courcelle, C. T., Cytomegaloviruses and their replication. In Knipe, D. M., Howley, P. M., Griffin, D. E. and Lamb, R. A. (Eds.), Fields virology. Lippincott Williams & Wilkins, Philadelphia, 2001, pp 2629-2673.
3. Pass, R. F., Cytomegalovirus. In Knipe, D. M., Howley, P. M., Griffin, D. E. and Lamb, R. A. (Eds.), Fields virology. Lippincott, Williams & Wilkins, Philadelphia, 2001, pp 2675-2705.
4. Romo, N., Fitó, M., Gumá, M., Sala, J., García, C., Ramos, R., Muntasell, A. et al., Association of atherosclerosis with expression of the LILRB1 receptor by human NK and T-cells supports the infectious burden hypothesis. Arterioscler. Thromb. Vasc. Biol. 2011. 31: 2314-2321.
5. Rodríguez-Caballero, A., García-Montero, A. C., Bárcena, P., Almeida, J., Ruiz-Cabello, F., Tabernero, M. D., Garrido, P. et al. Expanded cells in monoclonal TCR-alphabeta+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis recognize hCMV antigens. Blood 2008. 112: 4609-4616.
6. Mitchell, D. A., Xie, W., Schmittling, R., Learn, C., Friedman, A., McLendon, R. E. and Sampson, J. H., Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro. Oncol. 2008. 10: 10-18.
7. Koch, S., Solana, R., De la Rosa, O. and Pawelec, G., Human cytomegalovirus infection and T-cell immunosenescence: a mini review. Mech. Ageing Dev. 2006. 127: 538-543.
8. Stagno, S., Cytomegalovirus. In Remington, J. S. and Klein, J. O. (Eds.), Infectious diseases of the fetus and newborn infant. W.B. Saunders Company, Philadelphia, 2001, pp 389-424.
9. Dollard, S. C., Grosse, S. D. and Ross, D. S., New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev. Med. Virol. 2007. 17: 355-363.
10. Ludwig, A. and Hengel, H., Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe. Euro. Surveill. 2009. 14: 26-32.
11. Demmler, G. J., Congenital cytomegalovirus infection and disease. Semin. Pediatr. Infect. Dis. 1999. 10: 195-200.
12. Fowler, K. B., Stagno, S., Pass, R. F., Britt, W. J., Boll, T. J. and Alford, C. A., The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N. Engl. J. Med. 1992. 326: 663-667.
13. Boppana, S. B., Rivera, L. B., Fowler, K. B., Mach, M. and Britt, W. J., Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N. Engl. J. Med. 2001. 344: 1366-1371.
14. Pass, R. F., Fowler, K. B., Boppana, S. B., Britt, W. J. and Stagno, S., Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J. Clin. Virol. 2006. 35: 216-220.
15. Lilleri, D., Fornara, C., Furione, M., Zavattoni, M., Revello, M. G. and Gerna, G., Development of human cytomegalovirus-specific T-cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus. J. Infect. Dis. 2007. 195: 1062-1070.
16. Adler, S. P., Nigro, G. and Pereira, L., Recent advances in the prevention and treatment of congenital cytomegalovirus infections. Semin. Perinatol. 2007. 31: 10-18.
17. Nozawa, N., Fang-Hoover, J., Tabata, T., Maidji, E. and Pereira, L., Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream. J. Clin. Virol. 2009. 46(Suppl 4): S58-S63.
18. Lazzarotto, T., Gabrielli, L., Foschini, M. P., Lanari, M., Guerra, B., Eusebi, V. and Landini, M. P., Congenital cytomegalovirus infection in twin pregnancies: viral load in the amniotic fluid and pregnancy outcome. Pediatrics 2003. 112: e153-e157.
19. Cheeran, M. C., Lokensgard, J. R. and Schleiss, M. R., Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin. Microbiol. Rev. 2009. 22: 99-126.
20. López-Botet, M., Angulo, A. and Gumá, M., Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. Tissue Antigens 2004. 63: 195-203.
21. Marchant, A., Appay, V., Van Der Sande, M., Dulphy, N., Liesnard, C., Kidd, M., Kaye, S. et al., Mature CD8(+) T lymphocyte response to viral infection during fetal life. J. Clin. Invest 2003. 111: 1747-1755.
22. Gibson, L., Piccinini, G., Lilleri, D., Revello, M. G., Wang, Z., Markel, S., Diamond, D. J. et al., Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T-cell responses in children with congenital or postnatal human cytomegalovirus infection. J. Immunol. 2004. 172: 2256-2264.
23. Vermijlen, D., Brouwer, M., Donner, C., Liesnard, C., Tackoen, M., Van Rysselberge, M., Twite, N. et al., Human cytomegalovirus elicits fetal gammadelta T-cell responses in utero. J. Exp. Med. 2010. 207: 807-821.
24. Cauda, R., Prasthofer, E. F., Grossi, C. E., Whitley, R. J. and Pass, R. F., Congenital cytomegalovirus: immunological alterations. J. Med. Virol. 1987. 23: 41-49.
25. Harrison, C. J. and Caruso, N., Correlation of maternal and pup NK-like activity and TNF responses against cytomegalovirus to pregnancy outcome in inbred guinea pigs. J. Med. Virol. 2000. 60: 230-236.
26. Gumá, M., Angulo, A., Vilches, C., Gómez-Lozano, N., Malats, N. and López-Botet, M., Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004. 104: 3664-3671.
27. Monsivais-Urenda, A., Noyola-Cherpitel, D., Hernández-Salinas, A., García-Sepúlveda, C., Romo, N., Baranda, L., López-Botet, M. et al., Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Eur. J. Immunol. 2010. 40: 1418-1427.
28. Colonna, M., Navarro, F., Bellón, T., Llano, M., García, P., Samaridis, J., Angman, L. et al., A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 1997. 186: 1809-1818.
29. Cosman, D., Fanger, N., Borges, L., Kubin, M., Chin, W., Peterson, L. and Hsu, M. L., A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997. 7: 273-282.
30. Petersen, L., Roug, A. S., Skovbo, A., Thysen, A. H., Eskelund, C. W. and Hokland, M. E., The CD94/NKG2C-expressing NK cell subset is augmented in chronic lymphocytic leukemia patients with positive human cytomegalovirus serostatus. Viral Immunol. 2009. 22: 333-337.
31. Foley, B., Cooley, S., Verneris, M. R., Pitt, M., Curtsinger, J., Luo, X., López-Vergès, S. et al., Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C +natural killer cells with potent function. Blood 2012. 119: 2665-2674.
32. López-Vergès, S., Milush, J. M., Schwartz, B. S., Pando, M. J., Jarjoura, J., York, V. A., Houchins, J. P. et al., Expansion of a unique CD57NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 2011. 108: 14725-14732.
33. Della Chiesa, M., Falco, M., Podesta, M., Locatelli, F., Moretta, L., Frassoni, F. and Moretta, A., Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? Blood 2012. 119: 399-410.
34. Kuijpers, T. W., Baars, P. A., Dantin, C., van den Burg, M., van Lier, R. A. and Roosnek, E., Human NK cells can control CMV infection in the absence of T cells. Blood 2008. 112: 914-915.
35. Gumá, M., Cabrera, C., Erkizia, I., Bofill, M., Clotet, B., Ruiz, L. and López-Botet, M., Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J. Infect. Dis. 2006. 194: 38-41.
36. Mela, C. M. and Goodier, M. R., The contribution of cytomegalovirus to changes in NK cell receptor expression in HIV-1-infected individuals. J. Infect. Dis. 2007. 195: 158-159.
37. Brunetta, E., Fogli, M., Varchetta, S., Bozzo, L., Hudspeth, K. L., Marcenaro, E., Moretta, A. et al., Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection. AIDS 2010. 24: 27-34.
38. Bjorkström, N. K., Lindgren, T., Stoltz, M., Fauriat, C., Braun, M., Evander, M., Michaelsson, J. et al., Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 2011. 208: 13-21.
39. Petitdemange, C., Becquart, P., Wauquier, N., Béziat, V., Debré, P., Leroy, E. M. and Vieillard, V., Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog. 2011. 7: e1002268.
40. Béziat, V., Dalgard, O., Asselah, T., Halfon, P., Bedossa, P., Boudifa, A., Hervier, B. et al., CMV drives clonal expansion of NKG2C(+) NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 2011. 10: 447-457.
41. Gumá, M., Budt, M., Sáez, A., Brckalo, T., Hengel, H., Angulo, A. and López-Botet, M., Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006. 107: 3624-3631.
42. Sun, J. C., Beilke, J. N. and Lanier, L. L., Adaptive immune features of natural killer cells. Nature 2009. 457: 557-561.
43. Miyashita, R., Tsuchiya, N., Hikami, K., Kuroki, K., Fukazawa, T., Bijl, M., Kallenberg, C. G. et al., Molecular genetic analyses of human NKG2C (KLRC2) gene deletion. Int. Immunol. 2004. 16: 163-168.
44. Moraru, M., Cisneros, E., Gómez-Lozano, N., de Pablo, R., Portero, F., Cañizares, M., Vaquero, M. et al., Host genetic factors in susceptibility to herpes simplex type 1 virus infection: contribution of polymorphic genes at the interface of innate and adaptive immunity. J. Immunol. 2012. 188: 4412-4420.
45. de Vries, E., de Bruin-Versteeg, S., Comans-Bitter, W. M., de Groot, R., Hop, W. C., Boerma, G. J., Lotgering, F. K. et al., Longitudinal survey of lymphocyte subpopulations in the first year of life. Pediatr. Res. 2000. 47: 528-537.
46. Shearer, W. T., Rosenblatt, H. M., Gelman, R. S., Oyomopito, R., Plaeger, S., Stiehm, E. R., Wara, D. W. et al., Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J. Allergy Clin. Immunol. 2003. 112: 973-980.
47. Dokun, A. O., Kim, S., Smith, H. R., Kang, H. S., Chu, D. T. and Yokoyama, W. M., Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2001. 2: 951-956.
48. Magri, G., Muntasell, A., Romo, N., Sáez-Borderias, A., Pende, D., Geraghty, D. E., Hengel, H. et al., NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 2011. 117: 848-856.
49. Young, N. T., Uhrberg, M., Phillips, J. H., Lanier, L. L. and Parham, P., Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J. Immunol. 2001. 166: 3933-3941.
50. Antrobus, R. D., Khan, N., Hislop, A. D., Montamat-Sicotte, D., Garner, L. I., Rickinson, A. B., Moss, P. A. et al., Virus-specific cytotoxic T lymphocytes differentially express cell-surface leukocyte immunoglobulin-like receptor-1, an inhibitory receptor for class I major histocompatibility complex molecules. J. Infect. Dis. 2005. 191: 1842-1853.
51. Vivier, E. and Anfossi, N., Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat. Rev. Immunol. 2004. 4: 190-198.
52. Poon, K., Montamat-Sicotte, D., Cumberbatch, N., McMichael, A. J. and Callan, M. F., Expression of leukocyte immunoglobulin-like receptors and natural killer receptors on virus-specific CD8+ T cells during the evolution of Epstein-Barr virus-specific immune responses in vivo. Viral Immunol. 2005. 18: 513-522.
53. Bjorkström, N. K., Riese, P., Heuts, F., Andersson, S., Fauriat, C., Ivarsson, M. A., Bjorklund, A. T. et al., Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010. 116: 3853-3864.
54. Romagnani, C., Juelke, K., Falco, M., Morandi, B., D'Agostino, A., Costa, R., Ratto, G., et al. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J. Immunol. 2007. 178: 4947-4955.
55. Vossen, M. T., Matmati, M., Hertoghs, K. M., Baars, P. A., Gent, M. R., Leclercq, G., Hamann, J. et al., CD27 defines phenotypically and functionally different human NK cell subsets. J. Immunol. 2008. 180: 3739-3745.
56. Li, N. L., Davidson, C. L., Humar, A. and Burshtyn, D. N., Modulation of the inhibitory receptor leukocyte Ig-like receptor 1 on human natural killer cells. Front. Immunol. 2011. 2: 46.
57. Sáez-Borderias, A., Gumá, M., Angulo, A., Bellosillo, B., Pende, D. and López-Botet, M., Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. Eur. J. Immunol. 2006. 36: 3198-3206.
58. Breunis, W. B., van Mirre, E., Bruin, M., Geissler, J., de Boer, M., Peters, M., Roos, D. et al., Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood 2008. 111: 1029-1038.
59. González, E., Kulkarni, H., Bolivar, H., Mangano, A., Sánchez, R., Catano, G., Nibbs, R. J. et al., The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005. 307: 1434-1440.
60. Moraru, M., Cañizares, M., Muntasell, A., de Pablo, R., López-Botet, M. and Vilches, C., Assessment of copy-number variation in the NKG2C receptor gene in a single-tube and characterization of a reference cell panel, using standard polymerase chain reaction. Tissue Antigens 2012. 80: 184-187.